Sleep Apnea Diagnostic Systems Market: By Diagnostic Type (Actigraphy System, Polysomnography Device (PSG), Respiratory Polygraph, Single-Channel Screening Devices (Pulse Oximeter)), By End User (Sleep Laboratories & Hospitals, Home Care/Individuals) And By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Sleep Apnea Diagnostic Systems Market size was valued at USD 299.4 million in 2022 and is poised to grow at a CAGR of 7.1% from 2023 to 2029. Sleep apnea is a genuine rest issue that happens when a man's breathing is hindered amid rest. Individuals with untreated rest apnea quit breathing over and over amid their rest, in some cases several times. This implies the mind - and whatever remains of the body - may not get enough oxygen. The increasing number of rehabilitation centers, and awareness campaigns to assist patients with neurological disorders has led to a rise in the number of patients seeking treatments for neurological disorders. The risk of sleep apnea is greater in the age group of 50-60 years. According to UNO estimations in 2012, the geriatric population was about 810Mn and it is anticipated to grow to over 2000Mn people by 2050 globally. Expanded spotlight on R&D exercises for creating inventive items and key activities, for example, merger and securing and new item dispatch is the significant system embraced by these players to keep up their market position. For example, In May 2017, Philips consented to secure arrangements with Respiratory Technologies, Inc. The obtaining will grow Philip's sleep and respiratory care business.  

 

Sleep Apnea Diagnostic Systems Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.1%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

Sleep Apnea Diagnostic Systems Market Dynamics

Factors such as increase in the prevalence of sleep apnea globally is majorly driving the growth of the market. As per to the National Commission on Sleeping Disorders Research, globally about 38,000 deaths are occurring annually owing to the cardiovascular problems associated with sleepapnea. Furthermore, growing geriatric population, rising lifestyle changes, growing homecare acceptance, growing awareness about health, sleep disorders, improving healthcare infrastructure, introduction of new technologies and innovative products are the few factors which are boosting the growth of the market. However, strict regulatory procedures, side effects associated with the drugs, high competition in the market are the factors which are hampering the sleep apnea diagnostic systems growth.

Sleep Apnea Diagnostic Systems Market Segmentation

By Diagnostic Type

  • Actigraphy System
  • Polysomnography Device (PSG)
  • Respiratory Polygraph
  • Single-Channel Screening Devices (Pulse Oximeter )

By End User

  • Sleep Laboratories
  • Hospitals
  • Home Care/Individuals

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The sleep apnea diagnostic systems market size was valued at USD 299.4 million in 2022

The sleep apnea diagnostic systems market key players are Koninklijke Philips (Netherlands) ResMed (US) Fisher & Paykel Healthcare (New Zealand) SomnoMed (Australia) Compumedics (Australia) Whole You (US) Drive DeVilbiss Healthcare (US)

The sleep apnea diagnostic systems market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Key Features of the Report

  • The sleep apnea diagnostic systems market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Sleep Apnea Diagnostic Systems Market Introduction 
2.1.Global Sleep Apnea Diagnostic Systems Market  - Taxonomy
2.2.Global Sleep Apnea Diagnostic Systems Market  - Definitions
2.2.1. By Diagnostic Type
2.2.2. By End User
2.2.3. By Region
3.Global Sleep Apnea Diagnostic Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Sleep Apnea Diagnostic Systems Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Sleep Apnea Diagnostic Systems Market  By Diagnostic Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Actigraphy System
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Polysomnography Device (PSG)
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Respiratory Polygraph
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Single-Channel Screening Devices (Pulse Oximeter )
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Sleep Apnea Diagnostic Systems Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Sleep Laboratories
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hospitals
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Home Care/Individuals
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Sleep Apnea Diagnostic Systems Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Diagnostic Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Actigraphy System
8.1.2.Polysomnography Device (PSG)
8.1.3.Respiratory Polygraph
8.1.4.Single-Channel Screening Devices (Pulse Oximeter )
8.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Sleep Laboratories
8.2.2.Hospitals
8.2.3.Home Care/Individuals
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Diagnostic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Actigraphy System
9.1.2.Polysomnography Device (PSG)
9.1.3.Respiratory Polygraph
9.1.4.Single-Channel Screening Devices (Pulse Oximeter )
9.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Sleep Laboratories
9.2.2.Hospitals
9.2.3.Home Care/Individuals
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Diagnostic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Actigraphy System
10.1.2.Polysomnography Device (PSG)
10.1.3.Respiratory Polygraph
10.1.4.Single-Channel Screening Devices (Pulse Oximeter )
10.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Sleep Laboratories
10.2.2.Hospitals
10.2.3.Home Care/Individuals
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Diagnostic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Actigraphy System
11.1.2.Polysomnography Device (PSG)
11.1.3.Respiratory Polygraph
11.1.4.Single-Channel Screening Devices (Pulse Oximeter )
11.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Sleep Laboratories
11.2.2.Hospitals
11.2.3.Home Care/Individuals
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Sleep Apnea Diagnostic Systems Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Diagnostic Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Actigraphy System
12.1.2.Polysomnography Device (PSG)
12.1.3.Respiratory Polygraph
12.1.4.Single-Channel Screening Devices (Pulse Oximeter )
12.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Sleep Laboratories
12.2.2.Hospitals
12.2.3.Home Care/Individuals
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Koninklijke Philips (Netherlands)
13.2.2.ResMed (US)
13.2.3.Fisher & Paykel Healthcare (New Zealand)
13.2.4.SomnoMed (Australia)
13.2.5.Compumedics (Australia)
13.2.6.Whole You (US)
13.2.7.BMC Medical (China)
13.2.8.Braebon Medical (Canada)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Koninklijke Philips (Netherlands)
  • ResMed (US)
  • Fisher & Paykel Healthcare (New Zealand)
  • SomnoMed (Australia)
  • Compumedics (Australia)
  • Whole You (US)
  • Drive DeVilbiss Healthcare (US)
  • BMC Medical (China)
  • Braebon Medical (Canada)

Adjacent Markets